Sickle cell disease and related hemoglobinopathies

1. High-Yield Summary

• Molecular and Biophysical Basis: Sickle cell disease (SCD) results from a single nucleotide substitution in the beta-globin gene (HBB codon 6, GAG to GTG; glutamic acid to valine), producing abnormal hemoglobin S (HbS). Deoxygenation, cellular dehydration, and acidosis induce HbS polymerization into rigid 14-strand helical filaments, causing erythrocyte sickling, endothelial adherence, microvascular occlusion, tissue hypoxia, and widespread bone marrow necrosis.
• Genotypic Spectrum and Paradoxical Risk: Although homozygous sickle cell anemia (HbSS) produces the most profound chronic hemolytic anemia (baseline hemoglobin 6 to 9 g/dL) and systemic crises, symptomatic osteonecrosis of the femoral head (ONFH) is paradoxically most prevalent in hemoglobin SC disease (HbSC) and sickle beta-plus-thalassemia. This elevated risk stems from higher baseline hematocrit (hemoglobin 10 to 12 g/dL) and higher whole-blood viscosity creating greater microvascular sludging within end-arterial bone beds.
• Diagnostic Trilemma: Vaso-occlusive bone crisis (VOC) and acute osteomyelitis present identically with fever, leukocytosis, erythema, and severe focal bone pain. Dynamic differentiation hinges on serial C-reactive protein (CRP, which peaks rapidly at 48 to 72 hours and declines during uncomplicated VOC, but rises continuously in osteomyelitis) and contrast-enhanced MRI (distinguishing geographic infarct edema from focal cortical breakdown and subperiosteal abscess). Erythrocyte sedimentation rate (ESR) is falsely low and unreliable due to impaired rouleaux formation of sickled erythrocytes.
• Pathogen Predilection: Functional asplenia from recurrent splenic micro-infarctions, impaired alternative complement opsonization, and gastrointestinal mucosal ischemia predispose sickle cell patients to invasive infection with non-typhoidal Salmonella species, which account for up to 70% of osteomyelitis cases, followed by Staphylococcus aureus. Empiric antibiotic coverage must target both encapsulated enteric Gram-negative bacilli and staphylococcal organisms.
• Surgical Reconstruction Doctrine: Core decompression combined with autologous bone marrow aspirate concentrate (BMAC) preserves the native joint in early pre-collapse osteonecrosis (ARCO Stages I and II). Structural collapse (ARCO Stages III and IV) requires total hip arthroplasty (THA). Historic cemented implants failed catastrophically with loosening rates exceeding 40%; modern uncemented, highly porous titanium or tantalum cups and tapered femoral stems achieve greater than 90% survivorship at 10 years. Perioperative care mandates conservative transfusion targeting hemoglobin 10.0 g/dL while avoiding hyperviscosity (Hb greater than 10.5 g/dL), hypothermia, acidosis, and hypoxia.

2. Anatomy

Surgical intervention and pathological vulnerability in sickle cell hemoglobinopathies require detailed knowledge of epiphyseal arterial supplies, medullary bone microcirculation, intermuscular planes, and periarticular neurovascular danger zones.

Vascular Anatomy of the Femoral and Humeral Heads

The blood supply of the proximal femur is predominantly derived from the medial femoral circumflex artery (MFCA), a branch of the deep femoral artery. The MFCA courses posterior to the obturator externus muscle and anterior to the superior gemellus and quadratus femoris. It terminates in two to four lateral epiphyseal retinacular vessels that penetrate the joint capsule posterosuperiorly at the femoral neck-head junction. These terminal retinacular branches supply the lateral weight-bearing anterosuperior quadrant of the femoral head. The artery of the ligamentum teres (derived from the obturator or medial circumflex artery) provides negligible perfusion in mature skeletons, contributing less than 10% of total head vascularity. Because the subchondral epiphyseal circulation consists of terminal end-arterioles entering low-flow sinusoidal capillary networks, local microvascular thrombosis triggers rapid, non-collateralized osteocyte death and structural collapse.

In the proximal humerus, the anterior humeral circumflex artery (AHCA) branches into the anterolateral ascending artery, which traverses parallel to the long head of the biceps tendon within the bicipital groove before entering the humeral head as the arcuate artery. The posterior humeral circumflex artery (PHCA) provides collateral perfusion to the posterior head and greater tuberosity. The terminal subchondral capillary loops of the superior humeral articular surface mimic femoral architecture, leaving the humeral head vulnerable to ischemic infarction during microvascular sludging episodes.

Medullary Bone Circulation and Microvascular Sludging

The diaphyseal and metaphyseal bone circulation depends on high-pressure nutrient arteries entering through cortical nutrient canals and branching longitudinally into endosteal medullary networks. Blood traverses sluggish marrow sinusoids where physiological oxygen tension is low (pO2 20 to 30 mmHg) and hydrostatic pressures are elevated. In patients with sickle cell disease, low oxygen tension, hyperosmolarity, and endothelial activation trigger rapid erythrocyte sickling. Sickled red blood cells exhibit rigid elongation, occlude sinusoidal lumens, adhere to the vascular endothelium, and provoke microvascular thrombosis. The resulting tissue ischemia, cellular edema, and bone marrow necrosis elevate intraosseous pressure, further compromising collateral capillary inflow and creating an ischemic feedback cascade.

Surgical Approaches and Internervous Planes

• Direct Anterior Approach (Smith-Petersen modified): Utilizes the internervous plane between the femoral nerve (innervating sartorius and rectus femoris medially) and the superior gluteal nerve (innervating tensor fasciae latae and gluteus medius laterally). This intermuscular corridor provides direct acetabular access without detaching the abductor mechanism, lowering dislocation risk, but requires careful identification of the lateral femoral cutaneous nerve.
• Anterolateral Approach (Watson-Jones): Utilizes the plane between the superior gluteal nerve (tensor fasciae latae) and the femoral nerve (rectus femoris). Proximal development exposes the anterior gluteus medius, requiring partial anterior abductor detachment.
• Posterolateral Approach (Southern / Moore): Traverses through the gluteus maximus (innervated by the inferior gluteal nerve) along its muscle fibers without an internervous plane, followed by detachment of the piriformis, obturator internus, and gemelli short external rotators. It affords uninhibited exposure of the femoral canal and posterior column, ideal for complex femoral preparation in sclerotic sickle bone, but mandates anatomic capsulotendinous repair to safeguard against posterior dislocation.

Neurovascular Danger Zones

• Sciatic Nerve: Courses 1.5 to 2.0 cm posterior to the posterior acetabular wall, resting on the external rotators and quadratus femoris. Overzealous posterior retractor placement, aggressive soft-tissue release, thermal injury from electrocautery, or hematoma compression places the peroneal division at high risk for neuropraxia.
• Femoral Neurovascular Bundle: Situated immediately anterior to the anterior acetabular rim, separated only by the iliopsoas tendon and psoas bursa. Over-penetration of anterior acetabular wall retractors or deep pelvic pin placement risks direct laceration or compression of the femoral nerve and external iliac vessels.
• Superior Gluteal Nerve and Vessels: Exit the pelvis through the greater sciatic foramen above the piriformis. The neurovascular leash courses between gluteus medius and gluteus minimus, arborizing 3 to 5 cm proximal to the tip of the greater trochanter. Splitting the gluteus medius muscle more than 4 cm proximally during lateral exposures risks denervation of the anterior abductor muscle belly, leading to persistent Trendelenburg lurch.
• Lateral Femoral Cutaneous Nerve (LFCN): Crosses the anterior superior iliac spine (ASIS) within 1.0 to 1.5 cm medially or inferiorly. Retraction on the medial border of the tensor fasciae latae during the direct anterior approach can produce traction neuropraxia or painful meralgia paresthetica.

3. Pathogenesis

The pathogenesis of musculoskeletal pathology in sickle cell disease integrates genetic point mutations, biophysical hemoglobin polymerization, endothelial adhesion biology, microvascular thrombosis, and secondary immune system impairment.

Molecular Defect and Genotypic Variations

Sickle cell disease is an autosomal recessive disorder caused by a single nucleotide substitution in the HBB gene on the short arm of chromosome 11 (11p15.5). The mutation substitutes adenine with thymine (GAG to GTG) at codon 6 of the beta-globin chain, resulting in the replacement of hydrophilic glutamic acid with hydrophobic valine. The resulting abnormal hemoglobin tetramer (alpha-2/beta-S-2) is termed hemoglobin S (HbS). Several distinct genotypes produce orthopaedic pathology:

• HbSS (Sickle Cell Anemia): Homozygous inheritance with complete absence of normal adult hemoglobin A (HbA). Severe chronic hemolytic anemia (hemoglobin 6 to 9 g/dL), frequent systemic vaso-occlusive crises, early splenic autoinfarction, and extensive marrow hyperplasia.
• HbSC Disease: Double heterozygosity for HbS and HbC (where glutamic acid is replaced by lysine at codon 6). Patients exhibit milder chronic hemolytic anemia with higher baseline hemoglobin levels (10 to 12 g/dL). Paradoxically, this higher hematocrit increases whole-blood viscosity, predisposing patients to the highest incidence of femoral and humeral head osteonecrosis.
• Sickle Beta-Thalassemia (HbS-beta-0 and HbS-beta-+): Co-inheritance of the HbS allele with a beta-thalassemia mutation. HbS-beta-0 produces complete absence of normal beta chains and presents with a clinical severity identical to HbSS. HbS-beta-+ produces reduced amounts of normal beta chains, displaying milder anemia but significant osteonecrosis prevalence.
• Sickle Cell Trait (HbAS): Heterozygous carriers possessing one normal beta gene and one HbS gene. Generally asymptomatic with normal life expectancy and absent orthopaedic morbidity under physiological conditions, but capable of acute exertional sickling and rhabdomyolysis under extreme physical exhaustion, severe dehydration, or profound hypoxia at high altitudes.

Biophysical Sickling Cascade and Microvascular Occlusion

Under conditions of regional deoxygenation, acidosis, cellular dehydration, or hypothermia, HbS molecules undergo a conformational transition that exposes the hydrophobic valine residues on the beta-1 chain of one tetramer. This hydrophobic pocket docks with phenylalanine 85 and leucine 88 residues on the beta-2 chain of an adjacent tetramer. Nucleation occurs, leading to the formation of 14-strand helical polymer filaments. These intracellular polymers distort the flexible biconcave erythrocyte into a rigid, non-deformable sickle or holly-leaf conformation.

Repeated cycles of sickling and unsickling damage erythrocyte membrane architecture, causing potassium and water efflux through Gardos channels and creating dense, irreversibly sickled cells (ISCs). Intravascular hemolysis releases free cell-free hemoglobin and arginase into circulation. Free hemoglobin scavenges endothelial nitric oxide (NO) at equimolar concentrations, while arginase depletes L-arginine, the substrate for NO synthase. The resulting profound depletion of bioavailable NO impairs basal vasodilation, upregulates endothelial adhesion molecules (vascular cell adhesion molecule-1 [VCAM-1], intercellular adhesion molecule-1 [ICAM-1], and P-selectin), and activates platelets and circulating neutrophils.

Sickle erythrocytes express surface integrins, including very late antigen-4 (VLA-4 / alpha-4-beta-1) and CD36, which bind directly to endothelial VCAM-1 and plasma thrombospondin. Adherent sickled erythrocytes, activated neutrophils, and platelet microthrombi aggregate within post-capillary venules and low-flow sinusoidal bone marrow beds. The resultant microvascular occlusion produces bone marrow ischemia, acute cellular infarction of osteocytes and osteoblasts, and progressive osteonecrosis.

Immune Dysfunction and Salmonella Predilection

Patients with sickle cell disease exhibit marked susceptibility to bacterial osteomyelitis, with non-typhoidal Salmonella species representing the causative organism in up to 70% of confirmed cases. This distinct microbiological vulnerability stems from three interrelated biological factors:

• Functional Asplenia: Recurrent microvascular sickling within the splenic red pulp sinusoids causes progressive, repeated infarction and tissue fibrosis, leading to functional asplenia by 3 to 5 years of age (autosplenectomy). The loss of splenic reticuloendothelial macrophages compromises phagocytosis of encapsulated bacteria and impairs opsonization through defective alternative complement pathway activation (specifically deficient factor B and C3b coating).
• Gastrointestinal Mucosal Ischemia: Repetitive mesenteric micro-infarctions disrupt the mucosal epithelial barrier of the intestine, facilitating the transmural migration and hematogenous translocation of non-typhoidal Salmonella (*S. typhimurium*, *S. enteritidis*) into portal and systemic circulations.
• Ischemic Bone Nidus and Iron Overload: Areas of bone infarction contain dead osteocytes, stagnant hematomas, and devitalized medullary architecture that create a protected, poorly vascularized anaerobic environment ideal for bacterial colonization. Furthermore, chronic extravascular hemolysis and repeated red blood cell transfusions generate systemic iron overload (hemosiderosis), which impairs neutrophil oxidative killing and provides an abundant supply of serum iron that promotes rapid bacterial proliferation via siderophore-mediated iron acquisition.

4. Natural History

The natural history of sickle cell disease spans pediatric manifestations to debilitating adult degenerative osteoarticular destruction.

Epidemiology and Global Burden

Sickle cell disease is the most prevalent monogenic hemoglobin disorder worldwide, predominantly affecting populations of sub-Saharan African, Mediterranean, Middle Eastern, and South Asian ancestry. In the United States, sickle cell disease affects approximately 1 in 365 Black or African American births and 1 in 16,300 Hispanic American births, with over 100,000 individuals living with the disease. Global neonatal incidence exceeds 300,000 births annually. Universal newborn screening programs have significantly reduced infant mortality through early penicillin prophylaxis and conjugate pneumococcal vaccination.

Dactylitis (Hand-Foot Syndrome)

Dactylitis represents the earliest recognized musculoskeletal manifestation of sickle cell disease, occurring in 40% to 50% of infants between 6 months and 2 years of age as fetal hemoglobin (HbF) levels decline and are replaced by HbS. It presents as acute, painful, symmetric, non-erythematous or mildly erythematous soft-tissue swelling of the dorsum of the hands and feet. The condition results from microvascular infarction of the hematopoietic medullary marrow within tubular phalanges, metacarpals, and metatarsals. Although dactylitis episodes typically resolve spontaneously over 1 to 3 weeks with hydration and analgesia, recurrent ischemic episodes may cause premature physeal fusion, resulting in shortened digits (brachydactyly) or angular skeletal deformities.

Vaso-Occlusive Bone Crisis (VOC)

Acute vaso-occlusive crisis involving the skeletal system is the hallmark clinical event and primary reason for emergency department evaluation and hospital admission. Episodes are characterized by excruciating, deep somatic pain localized to the diaphyses of long bones (femur, tibia, humerus), the lumbar spine, or the thoracic cage. Episodes are triggered by environmental cold, physical exhaustion, emotional stress, dehydration, systemic infection, or acute hypoxemia. While many crises resolve without permanent structural damage, recurrent medullary infarctions cause progressive cumulative osteonecrosis and diffuse medullary fibrosis.

Osteonecrosis of the Femoral and Humeral Heads

Osteonecrosis of the femoral head (ONFH) is the most disabling orthopaedic complication of sickle cell disease, affecting 10% to 30% of homozygous HbSS patients and up to 50% of HbSC and HbS-beta-thalassemia patients by age 35. The disease is bilateral in 50% to 70% of cases. The natural history of symptomatic ONFH in sickle cell disease is relentless: untreated symptomatic lesions progress to mechanical subchondral collapse in greater than 90% of hips within two years of symptom onset. Even asymptomatic lesions identified on screening MRI demonstrate a high rate of progression, with over 70% developing symptoms and subsequent articular collapse over long-term follow-up when the necrosis exceeds 50% of the femoral head volume.

Osteonecrosis of the humeral head affects 5% to 10% of patients. Because the shoulder is a non-weight-bearing joint, structural collapse occurs more slowly and is often better tolerated than hip osteonecrosis. However, advanced humeral head collapse produces significant mechanical impingement, severe pain with overhead motion, joint stiffness, and secondary glenohumeral arthrosis.

Vertebral and Long Bone Deformities

Central microvascular infarction of the vertebral growth plates leads to characteristic central endplate depression with preservation of peripheral endplate height, producing the pathognomonic “H-shaped” or “Lincoln log” vertebrae seen on lateral radiographs. Compensatory medullary erythroid hyperplasia causes profound expansion of the marrow space, thinning of cortical bone, coarse trabecular coarsening, and systemic osteopenia. This structural compromise predisposes patients to pathological stress fractures, vertebral compression fractures, and acquired angular deformities such as genu valgum and tibiofibular bowing.

5. Clinical Presentation

Evaluation requires a systematic history and physical examination to differentiate self-limiting vaso-occlusive crises from acute joint infection, structural articular collapse, or systemic life-threatening crises.

History

• Pain Characteristics: Clinicians must distinguish the acute, deep, throbbing pain of a vaso-occlusive crisis from the insidious, activity-related mechanical groin pain characteristic of femoral head osteonecrosis. Groin pain radiating to the anterior thigh or knee that worsens with weight-bearing and twisting maneuvers signifies intra-articular hip pathology rather than an uncomplicated bone crisis.
• Constitutional and Infection Red Flags: High spiking fevers (temperature greater than 38.5 degrees Celsius), chills, night sweats, localized warmth, cutaneous erythema, or unremitting bone pain unresponsive to routine hydration and analgesia indicate acute bacterial osteomyelitis or septic arthritis.
• Triggers and Modifiers: Assess recent exposure to cold temperatures, swimming, prolonged air travel, strenuous athletic exertion, dehydration, concurrent upper respiratory or gastrointestinal infections, and recent surgical procedures.
• Hematologic Baseline: Establish the patient’s baseline hemoglobin, reticulocyte count, baseline steady-state white blood cell count, annual transfusion requirements, history of red cell alloantibodies, and adherence to disease-modifying therapy such as hydroxyurea.
• Pulmonary Symptoms: Promptly screen for cough, pleuritic chest pain, tachypnea, or dyspnea to rule out acute chest syndrome, which can develop concurrently with bone crises.

Physical Examination

Physical examination must evaluate localized skeletal tenderness, joint effusion, active and passive range of motion, neurovascular integrity, and gait disturbances (such as an antalgic or Trendelenburg gait). Provocative physical examination maneuvers identify intra-articular hip pathology and differentiate bone infarction from septic joint infection.

6. Imaging and Diagnostic Studies

Diagnostic imaging progresses systematically from plain radiography to multi-planar MRI and nuclear medicine studies, accompanied by targeted hematologic and microbiologic laboratories.

Radiographs

• Standard Pelvic and Hip Views: Anteroposterior (AP) pelvis, AP hip, and dedicated frog-leg lateral radiographs represent the primary imaging modalities. In early osteonecrosis, plain radiographs are frequently normal (Stage I) or show subtle patchy sclerosis and cystic radiolucencies in the anterosuperior femoral head (Stage II).
• Crescent Sign: A curvilinear subchondral radiolucent fracture line situated in the anterosuperior weight-bearing quadrant of the femoral head, seen best on the frog-leg lateral view. The crescent sign is pathognomonic for mechanical subchondral fatigue fracture (ARCO Stage III) and signifies impending or early structural collapse.
• Advanced Joint Collapse: Manifests as articular flattening, femoral head step-off deformity, loss of joint space sphericity, secondary acetabular cartilage loss, subchondral sclerosis, and marginal osteophyte formation (ARCO Stage IV).
• H-Shaped Vertebrae: Lateral spine radiographs demonstrate central step-off depression of both superior and inferior vertebral endplates with preservation of anterior and posterior vertebral margins, producing the classical “H-shaped” or “Lincoln log” vertebra resulting from microvascular infarction of central endplate arteries.
• Long Bone Findings: Radiographs display widened medullary cavities with cortical thinning from medullary hyperplasia, coarse trabecular architecture, periosteal new bone formation, and a “bone-within-a-bone” appearance (endosteal sclerosis enclosing necrotic cortical bone following prior diaphyseal infarction).

Advanced Imaging

• Magnetic Resonance Imaging (MRI): The definitive gold standard for early detection, staging, and therapeutic planning in osteonecrosis, with sensitivity and specificity exceeding 95%. T1-weighted images show a well-defined, low-signal serpiginous band circumscribing the necrotic bone segment in the anterosuperior femoral head. T2-weighted and short-tau inversion recovery (STIR) sequences reveal the pathognomonic “Double-Line Sign,” consisting of an outer low-intensity band (representing sclerotic, hyperdense reactive bone) and an inner high-intensity band (representing hyperemic, vascularized granulation tissue).
• Differentiating Bone Infarct from Acute Osteomyelitis: On MRI, an uncomplicated acute bone marrow infarct demonstrates a geographic central area of bone marrow edema on T2/STIR with preservation of overlying cortical margins and minimal adjacent soft-tissue fluid collections (subperiosteal fluid less than 2 mm). Contrast administration shows peripheral geographic rim enhancement with non-enhancing necrotic marrow. In contrast, acute osteomyelitis shows confluent, non-geographic marrow hyperintensity, cortical destruction, thick subperiosteal fluid collections (greater than 3 mm), and prominent soft-tissue abscesses with thick peripheral rim enhancement and the “penumbra sign” (a discrete hyperintense rim on unenhanced T1-weighted images).
• Nuclear Scintigraphy: Sequential Technetium-99m (Tc-99m) bone scintigraphy combined with Gallium-67 or Indium-111 labeled white blood cell (WBC) scintigraphy is helpful when MRI is contraindicated or inconclusive. During the initial 24 to 48 hours of an acute bone infarct, Tc-99m scans display a photopenic “cold spot” reflecting focal ischemia, while Gallium-67 scans show normal or reduced uptake. In acute osteomyelitis, all three phases of the Tc-99m bone scan demonstrate hypervascular “hot” uptake, with intense, incongruent focal uptake on Gallium-67 or Indium-111 WBC imaging.

Laboratory Studies

• Complete Blood Count (CBC) with Differential: Assesses baseline anemia (hemoglobin 6 to 9 g/dL in HbSS, 10 to 12 g/dL in HbSC). Chronic steady-state leukocytosis (10,000 to 15,000/mcL) is standard due to bone marrow demargination and splenic hypofunction. A marked left shift with significant bandemia (greater than 10% immature forms) strongly suggests acute bacterial infection rather than an uncomplicated vaso-occlusive crisis.
• Reticulocyte Count: Reflects compensatory erythropoietic drive (baseline 5% to 15%). A sudden decline in reticulocyte count (less than 1%) in the setting of acute anemia signals a life-threatening aplastic crisis, most frequently triggered by Parvovirus B19 infection.
• Inflammatory Biomarkers: Erythrocyte sedimentation rate (ESR) is falsely decreased and clinically uninformative because deformed, sickled erythrocytes cannot aggregate into standard rouleaux formations. Serial C-reactive protein (CRP) and serum procalcitonin are the essential dynamic biomarkers. In uncomplicated VOC, CRP rises moderately, peaks within 48 to 72 hours, and steadily resolves with hydration and crisis clearance. In acute bacterial osteomyelitis, CRP remains markedly elevated or rises progressively. A serum procalcitonin level exceeding 0.5 ng/mL demonstrates high specificity for invasive bacterial infection over aseptic bone crisis.
• Microbiological Cultures: Blood cultures (aerobic and anaerobic) must be obtained prior to initiating antimicrobial therapy, yielding positive isolates in up to 50% of osteomyelitis cases. Image-guided fine-needle aspiration of subperiosteal fluid collections or percutaneous bone biopsy represents the definitive gold standard for pathogen isolation and antibiotic susceptibility determination.

7. Classification

Accurate staging of osteonecrosis guides joint preservation versus reconstructive arthroplasty, while genotypic classification stratifies systemic complication risks.

ARCO (Association Research Circulation Osseous) Staging System for Osteonecrosis

Hemoglobinopathy Genotypes and Orthopaedic Phenotypes

8. Treatment

Treatment combines medical optimization of hemoglobinopathy physiology with stage-specific surgical interventions for osteonecrosis and infection.

Medical and Nonoperative Management

• Vaso-Occlusive Bone Crisis Protocol: Immediate, aggressive intravenous hydration using hypotonic fluids (such as 5% dextrose in 0.45% normal saline) to correct dehydration, reduce plasma osmolality, and decrease intracellular erythrocyte sickling. Scheduled multimodal analgesia incorporating intravenous opioids (morphine or hydromorphone via patient-controlled analgesia), acetaminophen, and nonsteroidal anti-inflammatory drugs (NSAIDs, with careful monitoring of renal function). Supplemental oxygen is administered only if oxygen saturation drops below 95% on room air, as hyperoxia suppresses erythropoietin production.
• Disease-Modifying Pharmacotherapy: Hydroxyurea (ribonucleotide reductase inhibitor) is the cornerstone medical therapy, stimulating fetal hemoglobin (HbF) production, lowering intracellular HbS concentrations, reducing circulating neutrophil counts, and significantly decreasing the frequency of vaso-occlusive crises, acute chest syndrome episodes, and transfusion requirements. Newer targeted agents include L-glutamine (reduces erythrocyte oxidative stress), Crizanlizumab (monoclonal antibody inhibiting P-selectin-mediated endothelial adhesion), and Voxelotor (HbS polymerization inhibitor that stabilizes the oxygenated hemoglobin state).
• Empiric Antimicrobial Therapy for Osteomyelitis: When acute osteomyelitis or septic arthritis is suspected, empiric intravenous antibiotic therapy must be initiated immediately following blood and fluid cultures. The regimen must provide bactericidal coverage against both non-typhoidal Salmonella species and Staphylococcus aureus (including MRSA). First-line therapy consists of an intravenous third-generation cephalosporin (Ceftriaxone 2 g IV every 24 hours) combined with Vancomycin (15 to 20 mg/kg IV every 8 to 12 hours, targeting trough levels of 15 to 20 mcg/mL). In patients with severe beta-lactam anaphylaxis, a fluoroquinolone (Ciprofloxacin 400 mg IV every 12 hours) is substituted for ceftriaxone. Total antibiotic duration is 4 to 6 weeks, with transition to high-bioavailability oral agents once clinical improvement and inflammatory marker downtrending are confirmed.
• Nonoperative Limitations in Osteonecrosis: Protected weight-bearing, crutch ambulation, core physical therapy, and antiresorptive medications (bisphosphonates) have been thoroughly investigated. Nonoperative treatment uniformly fails to prevent structural femoral head collapse in symptomatic sickle cell osteonecrosis, progressing to collapse in over 90% of hips within two years. Conservative management is strictly palliative, reserved only for patients medically unfit for surgery.

Operative Management

The goals of surgery are preservation of the native articular surface in pre-collapse stages, durable joint reconstruction in collapsed stages, and eradication of musculoskeletal infection.

• Core Decompression with Biological Augmentation (ARCO Stages I and II): Indicated for pre-collapse osteonecrosis with intact femoral head sphericity. Multiple percutaneous drillings (using 3.2 mm to 4.5 mm cannulated drills or Steinman pins under fluoroscopic guidance) are preferred over single large (8 to 10 mm) trephine drilling. Multiple drilling reduces intraosseous venous hypertension, opens sclerotic vascular channels, and minimizes the risk of postoperative subtrochanteric stress fractures. Percutaneous core decompression augmented with autologous bone marrow aspirate concentrate (BMAC) harvested from the iliac crest introduces mesenchymal stem cells (MSCs) and angiogenic cytokines into the necrotic zone, significantly improving survivorship and delaying mechanical collapse compared to isolated decompression.
• Total Hip Arthroplasty (ARCO Stages III and IV): The definitive reconstructive procedure for collapsed osteonecrosis (crescent sign, articular flattening, secondary osteoarthritis). Modern uncemented fixation is the absolute standard of care. Porous titanium or tantalum acetabular shells with multi-hole fixation allow supplemental dome screw stabilization. Femoral reconstruction requires tapered, wedge-shaped or cylindrical uncemented titanium stems with extensive porous coating or hydroxyapatite application to achieve stable biological scratch fit. Modern bearing couples, particularly ceramic-on-crosslinked polyethylene (CoP), are utilized to minimize volumetric wear and late periprosthetic osteolysis in young, active patients.
• Surgical Debridement of Infection: Acute septic arthritis mandates emergency open or arthroscopic joint irrigation and debridement to prevent chondrolysis. Acute osteomyelitis with documented subperiosteal or intramedullary abscess requires formal cortical windowing, thorough debridement of necrotic sequestra, pulsatile irrigation, and temporary dead-space management using antibiotic-impregnated polymethylmethacrylate (PMMA) or bioabsorbable calcium sulfate beads.

Indications, Contraindications, and Perioperative Protocols

• Objective Indications: Core decompression with BMAC is indicated for ARCO Stage I or II lesions involving greater than 15% to 20% of the femoral head or with a Kerboul necrosis angle exceeding 200 degrees in symptomatic patients with preserved sphericity. Total Hip Arthroplasty is indicated for symptomatic ARCO Stage III (subchondral collapse or crescent sign) and Stage IV (secondary joint degeneration) disease where conservative measures have failed.
• Absolute Contraindications: Performing joint preservation in ARCO Stage III/IV disease (articular collapse greater than 2 mm); performing elective THA during an acute vaso-occlusive crisis, active systemic bacteremia, active osteomyelitis, or uncontrolled acute chest syndrome; and unoptimized perioperative anemia (hemoglobin less than 8 g/dL).
• Preoperative Transfusion Protocol: Based on the seminal prospective randomized controlled trial by Vichinsky and colleagues (Preoperative Transfusion in Sickle Cell Disease Study Group), simple blood transfusion targeting a preoperative hemoglobin concentration of 10.0 g/dL (target range: 9.5 to 10.5 g/dL) is the gold standard protocol for elective major orthopaedic procedures. Simple transfusion is as effective as aggressive exchange transfusion (targeting HbS levels below 30%) in preventing perioperative vaso-occlusive complications and acute chest syndrome, while reducing transfusion-related adverse events (alloimmunization, hemolytic reactions, viral transmission) by 50%. Aggressive exchange transfusion is reserved exclusively for major thoracic or spine deformity cases or patients with baseline hemoglobin already exceeding 9.0 g/dL. Clinicians must strictly avoid over-transfusion beyond 10.5 to 11.0 g/dL, as excessive red cell mass triggers a steep increase in blood viscosity that precipitates fatal microvascular sludging and acute chest syndrome.
• Intraoperative and Anesthetic Safety Rules: Continuous maintenance of body normothermia utilizing forced-air warming blankets and warmed intravenous fluids (hypothermia induces intense peripheral vasoconstriction and massive erythrocyte sickling); maintenance of adequate intravascular volume with intravenous fluid administration at 1.5 times maintenance; continuous oxygenation targeting arterial oxygen saturation (SpO2) above 96%; strict avoidance of hypercapnia and systemic acidosis; and rapid operative execution with meticulous bipolar hemostasis.

9. Outcome

Clinical outcomes in sickle cell orthopaedic surgery are governed by the stage of disease at intervention, the surgical technique employed, and rigorous perioperative medical optimization.

Core Decompression and Joint Preservation Survivorship

Long-term prospective investigations demonstrate that isolated core decompression in early pre-collapse stages (ARCO Stage I and II) achieves symptomatic pain relief in 60% to 75% of hips, but mechanical collapse occurs in 35% to 50% of hips within 5 years. When core decompression is augmented with autologous bone marrow aspirate concentrate (BMAC) containing viable osteoprogenitor cells, 10-year joint preservation survivorship improves significantly to greater than 75% to 80% in Stage I and II hips, with substantial reduction in subsequent arthroplasty conversion. In contrast, performing core decompression after subchondral collapse (Stage III or IV) yields disastrous outcomes, with over 80% progressing to symptomatic failure and conversion to THA within 18 months.

Modern Total Hip Arthroplasty Survivorship

Historically, total hip arthroplasty in sickle cell disease was associated with unacceptably high rates of mechanical failure. First-generation and second-generation cemented implants demonstrated aseptic loosening rates exceeding 40% to 50% within 5 to 10 years, caused by ongoing bone marrow necrosis and compromised cement-bone interlock amidst osteopenic, vascularly challenged bone. Modern uncemented total hip arthroplasty utilizing highly porous titanium or tantalum acetabular shells, tapered titanium femoral stems with circumferential porous or hydroxyapatite coating, and modern ceramic-on-crosslinked polyethylene bearings has transformed clinical durability. Contemporary multicenter registry data and systematic reviews demonstrate 10-year implant survivorship exceeding 90% to 94% free from aseptic loosening.

Functional and Patient-Reported Outcome Measures

Total hip arthroplasty achieves dramatic improvements in patient-reported outcome measures. Mean Harris Hip Scores (HHS) improve from severe preoperative disability (mean score 38 to 45 points) to good-to-excellent postoperative function (mean score 82 to 88 points). Validated disease-specific metrics, including the Short Form-36 (SF-36) physical component score and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), demonstrate statistically significant and clinically meaningful gains in mobility, independent ambulation, and pain relief. Despite these successes, functional scores in sickle cell patients remain slightly lower than in age-matched non-sickle osteonecrosis cohorts due to chronic systemic anemia, recurrent bone crises in adjacent skeletal regions, and high rates of bilateral joint involvement.

10. Complications

Orthopaedic intervention in sickle cell disease carries a substantial complication profile that spans intraoperative technical challenges, early life-threatening systemic crises, and late reconstructive failures.

11. Pearls and Pitfalls

Successful management demands nuanced surgical technique, disciplined hematologic coordination, and high diagnostic vigilance.

• Diagnostic Differentiation Pearl: Never rely on erythrocyte sedimentation rate (ESR) to rule in or rule out infection in sickle cell disease. ESR is falsely low due to the physical inability of sickled red cells to aggregate into rouleaux stacks. Rely strictly on serial C-reactive protein (CRP), serum procalcitonin, and contrast-enhanced MRI. An uncomplicated vaso-occlusive crisis demonstrates a CRP that peaks by 48 to 72 hours and rapidly declines; a continuously rising or persistently elevated CRP past 72 hours represents acute osteomyelitis until proven otherwise.
• Antimicrobial Selection Pearl: Avoid standard first-generation cephalosporin (Cefazolin) monotherapy when treating presumed skeletal infection in sickle cell patients. The high prevalence of non-typhoidal Salmonella species mandates empiric third-generation cephalosporin (Ceftriaxone) coverage, combined with Vancomycin to target community-acquired methicillin-resistant Staphylococcus aureus (MRSA), until definitive deep culture isolates are identified.
• Femoral Canal Preparation Pearl: The sickle femur often features a completely obliterated medullary canal filled with sclerotic endosteal bone (“calcified marrow plug”), accompanied by thinned, brittle cortices. Attempting to drive standard straight broaches into this canal will predictably lead to broach deflection and catastrophic anterior or lateral cortical blowout. Master surgeons initiate canal entry under fluoroscopic visualization using a high-speed burr or narrow, flexible hand reamers, confirming central alignment within the canal before introducing progressive broaches.
• The Hyperviscosity Transfusion Trap: Never transfuse a patient with sickle cell disease to normal adult hemoglobin levels (greater than 10.5 to 11.0 g/dL). Doing so exponentially increases whole-blood viscosity in the presence of circulating rigid sickle erythrocytes, precipitating widespread microvascular stasis, acute chest syndrome, cerebral infarction, and death. Target a hemoglobin of strictly 9.5 to 10.0 g/dL.
• Pulmonary Atelectasis and Chest Syndrome Prevention: Postoperative hypoventilation resulting from unmanaged surgical pain and splinting is the leading trigger converting a routine recovery into fatal acute chest syndrome. Enforce mandatory incentive spirometry (10 breaths every hour while awake), provide regional multimodal analgesia, maintain supplemental oxygen if room air saturation drops below 95%, and mobilize patients out of bed on postoperative day one.

12. Controversy

Several clinical and operative strategies remain active areas of debate within orthopaedic surgery and hematology.

Biological Augmentation of Core Decompression

While autologous bone marrow aspirate concentrate (BMAC) combined with core decompression has demonstrated promising long-term survivorship in early-stage osteonecrosis, controversy exists regarding the biological potency of sickle cell bone marrow. Repeated cycles of medullary sickling, ischemia-reperfusion injury, and chronic marrow hyperplasia lead to premature depletion of viable mesenchymal stem cells (MSCs) and colony-forming unit-fibroblasts (CFU-F) in sickle cell patients compared to healthy controls. Proponents argue that local decompression and concentrated cytokine delivery still provide sufficient biological stimulation to halt structural collapse. Others advocate exploring allogeneic MSC sources, cellular expansion protocols, or synthetic osteoinductive scaffolds to overcome the intrinsic biological limitations of sickle marrow.

Tourniquet Safety in Extremity Surgery

Pneumatic tourniquet application during extremity surgery in sickle cell patients has historically been considered an absolute contraindication. Traditional surgical teaching argued that complete arterial occlusion, tissue hypoxia, localized acidosis, and venous stasis beneath and distal to the tourniquet would trigger massive erythrocyte sickling and disastrous limb-threatening necrosis upon cuff deflation. Modern clinical series challenge this dogmatic contraindication, demonstrating that pneumatic tourniquets can be utilized safely in distal extremity procedures under strict protocols: complete limb exsanguination using an Esmarch bandage, limited inflation times (less than 60 minutes), modern low-pressure contour cuffs, and continuous maintenance of systemic normothermia, hyperhydration, and oxygenation. Nevertheless, many surgeons avoid tourniquets entirely in major reconstructions, opting for meticulous bipolar electrocautery and local hemostatic agents.

Conservative Versus Aggressive Preoperative Transfusion Strategy

Following the landmark 1995 NEJM trial by Vichinsky and colleagues demonstrating clinical equivalence between simple transfusion (target Hb 10 g/dL) and aggressive exchange transfusion (target HbS less than 30%) with half the transfusion-related adverse events, conservative simple transfusion became standard international practice. However, controversy persists in specific high-demand surgical scenarios. Proponents of aggressive exchange transfusion argue that complex spine deformity corrections, prolonged pelvic reconstructions, or patients with high baseline hemoglobin levels (greater than 9.0 g/dL, where simple transfusion risks hyperviscosity) derive superior protection from exchange transfusion by actively clearing circulating HbS tetramers down to less than 30%. Recent multicenter hematology guidelines recommend individualized risk stratification, utilizing simple transfusion for routine arthroplasty and reserving exchange transfusion for major cavitary surgery or patients with a history of recurrent severe acute chest syndrome.

13. Evidence-Based Synthesis

Modern clinical decision-making is grounded in high-quality randomized controlled trials and prospective registry analyses, corroborated by seminal biomechanical and anatomical descriptions.

14. References

• Vichinsky EP, Haberkern CM, Neumayr L et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group. N Engl J Med. 1995. doi:10.1056/NEJM199507273330402 [Level I: Randomized Controlled Trial]
• Milner PF, Kraus AP, Sebes JI et al. Sickle cell disease as a cause of osteonecrosis of the femoral head. N Engl J Med. 1991. doi:10.1056/NEJM199111213252104 [Level II: Prospective Multicenter Cohort Study (CSSCD)]
• Hernigou P, Bachir D, Galacteros F. The natural history of symptomatic osteonecrosis in adults with sickle-cell disease. J Bone Joint Surg Am. 2003. doi:10.2106/00004623-200303000-00016 [Level IV: Prospective Natural History Cohort Study]
• Hernigou P, Habibi A, Bachir D et al. The natural history of asymptomatic osteonecrosis of the femoral head in adults with sickle cell disease. J Bone Joint Surg Am. 2006. doi:10.2106/JBJS.E.01455 [Level IV: Prospective Natural History Cohort Study]
• Hernigou P, Housset V, Pariat J et al. Total hip arthroplasty for sickle cell osteonecrosis: guidelines for perioperative management. EFORT Open Rev. 2020. doi:10.1302/2058-5241.5.190073 [Level IV: Systematic Review & Clinical Consensus Guidelines]

15. Master Class Pro-Tip

When preparing the femoral canal during total hip arthroplasty in a patient with sickle cell disease, never attempt to initiate canal entry with a standard starter broach. The proximal femur in chronic hemoglobinopathy is characterized by dense, endosteal neo-ossification that completely bridges the medullary canal, combined with paper-thin, fragile cortices. Driving a straight broach against this calcified medullary plug will reliably deflect the instrument into the softer anterior or lateral cortex, causing an immediate catastrophic cortical perforation. Instead, open the femoral canal under direct fluoroscopic guidance using an entry reamer, high-speed carbide burr, or rigid cannulated hand reamers. Establish the true anatomical central axis down past the lesser trochanter before introducing progressive compaction broaches. Pair this technical discipline with strict hematologic stewardship: maintain a target hemoglobin of strictly 9.5 to 10.0 g/dL, enforce forced-air normothermia throughout the case, and institute mandatory hourly incentive spirometry beginning immediately in the post-anesthesia recovery unit to eliminate the risk of fatal acute chest syndrome.

Master Class Surgical Pearl: Femoral Canal Preparation and Perioperative Stewardship in Sickle Cell Total Hip Arthroplasty